Publication Database

Polysulfates block SARS‐CoV‐2 uptake through electrostatic interactions (2021)

Art

Zeitschriftenartikel / wissenschaftlicher Beitrag

Autoren

Nie, Chuanxiong

Pouyan, Paria

Lauster, Daniel

Trimpert, Jakob (WE 5)

Kerkhoff, Yannic

Szekeres, Gergo Peter

Wallert, Matthias

Block, Stephan

Sahoo, Anil Kumar

Dernedde, Jens

Pagel, Kevin

Kaufer, Benedikt B. (WE 5)

Netz, Roland R.

Ballauff, Matthias

Haag, Rainer

Quelle

Angewandte Chemie : a journal of the Gesellschaft Deutscher Chemiker. - International edition

Bandzählung: 60

Heftzählung: 29

Seiten: 15870 – 15878

ISSN: 1433-7851

Sprache

Englisch

Verweise

URL (Volltext): https://onlinelibrary.wiley.com/doi/10.1002/anie.202102717

DOI: 10.1002/anie.202102717

Pubmed: 33860605

Kontakt

Institut für Virologie

Robert-von-Ostertag-Str. 7-13
14163 Berlin
+49 30 838 51833
virologie@vetmed.fu-berlin.de

Abstract / Zusammenfassung

Here we report that negatively charged polysulfates can bind to the spike protein of SARS-CoV-2 via electrostatic interactions. Using a plaque reduction assay, we compare inhibition of SARS-CoV-2 by heparin, pentosan sulfate, linear polyglycerol sulfate (LPGS) and hyperbranched polyglycerol sulfate (HPGS). Highly sulfated LPGS is the optimal inhibitor, with an IC50 of 67 μg mL-1 (approx. 1.6 μm). This synthetic polysulfate exhibits more than 60-fold higher virus inhibitory activity than heparin (IC50 : 4084 μg mL-1 ), along with much lower anticoagulant activity. Furthermore, in molecular dynamics simulations, we verified that LPGS can bind more strongly to the spike protein than heparin, and that LPGS can interact even more with the spike protein of the new N501Y and E484K variants. Our study demonstrates that the entry of SARS-CoV-2 into host cells can be blocked via electrostatic interactions, therefore LPGS can serve as a blueprint for the design of novel viral inhibitors of SARS-CoV-2.